Supriya Vishwakarma
Overview
Explore the profile of Supriya Vishwakarma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tiwari S, Pandey R, Kumar V, Das S, Gupta V, Vishwakarma S, et al.
Cancer Biomark
. 2023 Aug;
38(2):203-214.
PMID: 37545224
Background: miRNAs play a crucial role in the genesis of cancer, either as tumor suppressor genes or as oncogenes. Single Nucleotide Polymorphisms (SNPs) in the seed region of microRNAs (miRNAs)...
2.
Pandey R, Nema R, Vishwakarma S, Singh A, Mohan S, Patel P, et al.
Asian Pac J Cancer Prev
. 2023 Jul;
24(7):2353-2360.
PMID: 37505766
Oral squamous cell carcinoma (OSCC) is the most common type of cancer among men in the Indian subcontinent. Cytokines regulate inflammation and angiogenesis in a variety of cancers. Genetic variability...
3.
Joshi B, Shankar U, Vishwakarma S, Kumar A, Kumar A, Joshi D, et al.
ACS Appl Bio Mater
. 2023 May;
6(5):1943-1952.
PMID: 37126316
Theranostic nanoparticulate systems (TNPs) have shown potential in addressing problems related to spatial localization and temporally controlled release of drugs with the capabilities of real-time imaging to evaluate the progress...
4.
Vishwakarma S, Joshi D, Pandey R, Das S, Mukhopadhyay S, Rai R, et al.
Cureus
. 2022 May;
14(3):e23553.
PMID: 35494957
Background Sphingosine-1-phosphate (S1P) is a potent oncogenic lipid. Intracellular levels of S1P are tightly regulated by eight S1P-metabolizing enzymes. S1P synthesis is catalyzed by two sphingosine kinases, i.e., sphingosine kinase...
5.
Vishwakarma S, Arya N, Kumar A
Curr Drug Targets
. 2021 Dec;
23(6):559-573.
PMID: 34879798
The tumor microenvironment (TME) consists of cancer cells that interact with stromal components such as the extracellular matrix, blood, and lymphatic networks, fibroblasts, adipocytes, and the cells of the immune...
6.
Nema S, Kallianpur S, Kumar A, Nema R, Vishwakarma S, Nema S
J Oral Maxillofac Pathol
. 2021 Aug;
25(1):105-109.
PMID: 34349419
Context: The receptor tyrosine kinase-like orphan receptor 1 (ROR1) is a transmembrane protein of the receptor tyrosine kinase family. The expression of ROR1 has been linked to cancers. Aims: This...
7.
Vishwakarma S, Pandey R, Singh R, Gothalwal R, Kumar A
J Biosci
. 2021 Jan;
45.
PMID: 33410422
Long non-coding RNAs (lncRNAs) are a group of non-protein-coding RNAs which are longer than 200 nucleotides. LncRNAs play important roles in epigenetic modification, transcription and post-transcriptional regulation, maintenance of normal...
8.
Vishwakarma S, Agarwal R, Goel S, Panday R, Singh R, Sukumaran R, et al.
Cancer Invest
. 2017 Feb;
35(2):139-141.
PMID: 28135860
We have determined the gene expression of sphingosine-1-phosphate (S1P) metabolizing enzymes (SphK1, SphK2, SGPL1, SGPP1, SGPP2, PPAP2A, PPAP2B, and PPAP2C) by quantitative real-time polymerase chain reaction in tumor tissues and...
9.
Nema R, Vishwakarma S, Agarwal R, Panday R, Kumar A
Onco Targets Ther
. 2016 Jun;
9:3269-80.
PMID: 27330306
Head and neck squamous cell carcinoma (HNSCC) is the sixth most frequent cancer type, with an annual incidence of approximately half a million people worldwide. It has a high recurrence...